{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-080308","form_type":"8-K","ticker":"BRNS","cik":"0001828185","company_name":"Barinthus Biotherapeutics plc.","filed_at":"2026-07-02T20:05:21+00:00","discovered_at":"2026-07-02T20:07:00.641354+00:00","generated_at":"2026-07-02T20:07:25.518855+00:00","sec_items":["5.07","8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Barinthus Biotherapeutics gets Nasdaq extension to Dec 28, 2026; listing moved to Capital Market","bullets":["Received 180-day extension from Nasdaq until Dec 28, 2026 to regain $1.00 minimum bid price for ADSs.","ADS listing transferred from Nasdaq Global Market to Nasdaq Capital Market effective July 2, 2026.","Company may consider reverse stock split to regain compliance; no assurance of success.","If bid price does not close at $1.00 for 10 consecutive days by Dec 28, 2026, ADSs may be delisted."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-080308","json":"https://secwatch.observer/filing/0001104659-26-080308.json","markdown":"https://secwatch.observer/filing/0001104659-26-080308.md","text":"https://secwatch.observer/filing/0001104659-26-080308.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828185/000110465926080308/0001104659-26-080308-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828185/000110465926080308/tm2619582d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T20:07:25.518855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}